Physician profile
Gary Miller
NPI 1528027430
$482.16
in general payments reported to CMS, 2019-2025
12 companies · $68.90 in 2025
The $68.90 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $25.23 · 2021: $16.79 · 2023: $59.18 · 2024: $139 · 2025: $68.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $267.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $266.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $124.46 | 2019 | |
| Smith+Nephew, INC. | $113.85 | 2020-2024 | Collagenase Santyl |
| Neurocrine Biosciences, INC. | $57.83 | 2024 | Ingrezza |
| Otsuka America Pharmaceutical, INC. | $35.60 | 2023-2025 | Rexulti, Nuedexta |
| Harmony Biosciences LLC | $31.12 | 2025 | |
| Tactile Systems Technology INC | $28.45 | 2024 | Entre Plus, Flexitouch Plus |
| Astrazeneca Pharmaceuticals LP | $22.36 | 2025 | |
| Abbvie INC. | $19.39 | 2023 | |
| Avanir Pharmaceuticals, INC. | $17.65 | 2019 | |
| 3m Company | $17.02 | 2019 | |
| Coltene Whaledent INC. | $14.43 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Miller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.